Research > ETFs > ETF / ETP Commentary > 

How Effective N Reveals True Portfolio Diversification

Diversification goes beyond simply the amount of holdings within a fund. In the case of market-cap-weighted benchmarks, concentration risk from megacap dominance can render hundreds of underlying constituents practically invisible. During a recent TMX VettaFi webcast, Brent Leadbetter, head of RAFI Distribution at TMX VettaFi, explained why evaluating “effective N” can be an essential tool for uncovering hidden concentration risk.Calculated as the inverse of the Herfindahl-Hirschman Index, effective N translates a portfolio into the equivalent number of equally weighted stocks. The metric ultimately strips away the illusion of diversification by revealing how many stocks genuinely drive the performance of a fund. “So if you have an effective N of 10, that means that your portfolio acts like an equally weighted basket of 10 stocks,” explained Leadbetter.Key Takeaways: Effective N reveals true portfolio diversification by translating holdings into the equivalent number of equally weighted stocks, exposing when a handful of top-heavy names dominate fund performance. Despite holding hundreds of stocks, traditional cap-weighted benchmarks behave like a concentrated basket of just a few dozen names, whereas fundamental-weighted strategies can deliver more than double the effective diversification. By anchoring weights to economic footprint rather than share price, a fundamental strategy can help insulate core equity allocations from megacap drawdown risk. See More: Rob Arnott, Cinthia Murphy Discuss Smart Beta EvolutionPRF vs. SPY: Diversification in ActionComparing the SPDR S&P 500 ETF Trust (SPY A-) against the fundamental-weighted Invesco RAFI US 1000 ETF (PRF A-) highlights the concentration contrast in funds using effective N. Despite holding 504 stocks (as of November 16, 2026), SPY posts an effective N of just 48.3. This ultimately means the benchmark behaves like an equally weighted basket of fewer than 50 stocks. Conversely, PRF achieves an effective N of 114.47 across 989 holdings, delivering more than double the effective diversification. This gap in concentration is equally clear at the top of each portfolio. SPY’s top 10 holdings command 36.98% of the fund, led by Apple at 7.98%. By anchoring weights to economic footprint rather than share price in a typical market-cap-weighted approach, PRF has a top-10 concentration of 23.28% in comparison. Its largest single position is also Apple, but at 4.86%. Furthermore, PRF posts a higher effective holdings ratio, confirming more balanced capital deployment across its portfolio.Portfolio Implications of Effective NAs mentioned, understanding a fund’s effective N helps investors verify whether their core equity allocations are truly diversified or quietly concentrated in a handful of top-heavy names. Heavy portfolio concentration could leave investors vulnerable to single-stock or sector-specific drawdowns. “One of the reasons many of us started investing in indices in the first place was to get diversification,” Leadbetter emphasized. “You’re not getting the same level of diversification today in the S&P that you’ve gotten historically, because of how concentrated it has become at the top of the market.” For investors, PRF’s higher effective N means portfolio outcomes are less tethered to a handful of expensive megacaps. As such, the fund provides a fundamentally grounded option that can serve as a core equities allocation or a complement to an existing core equities exposure. For more news, information, and strategy, visit the Smart Beta Content Hub. VettaFi LLC (“VettaFi”) is the index provider for PRF, for which it receives an index licensing fee. However, PRF is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of PRF.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.